Journal
ACS MEDICINAL CHEMISTRY LETTERS
Volume 5, Issue 2, Pages 178-182Publisher
AMER CHEMICAL SOC
DOI: 10.1021/ml400447v
Keywords
Malaria; natural products; total synthesis
Categories
Funding
- Australian Research Council (ARC) [FT0991213]
- ARC [LE0668477, LE0237908]
- National Health and Medical Research Council (NHMRC) [APP1024314]
Ask authors/readers for more resources
Thiaplakortone A (3a), an antimalarial natural product, was prepared by an operationally simple and scalable synthesis. In our efforts to deliver a lead compound with improved potency, metabolic stability, and selectivity, the synthesis was diverted to access a series of analogues. Compounds, 3a-d showed nanomolar activity against the chloroquine-sensitive (3D7) Plasmodium falciparum line and were more active against the chloroquine- and mefloquine-resistant (Dd2) P. falciparum line. All compounds are Rule-of-5 compliant, and we show that metabolic stability can be enhanced via modification at either the primary or pyrrole nitrogen. These promising results lay the foundation for the development of this structurally unprecedented natural product.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available